She is CombiGene’s new CSO

CombiGene’s former Director Preclinical Development Annika Ericsson has taken over the role of the company’s Chief Scientific Officer. BioStock contacted Ericsson to learn more about her near-term priorities and long-term goals.
– We know that CG01 has great potential thanks to the out-licensing to Spark. I also see enormous potential in our pain project, which shows impressive preclinical data, says Annika Ericsson.

Read the article from BioStock here: She is CombiGene’s new CSO – BioStock